Genmab A/S ADS (GMAB) Earnings Date & Reports

A.I. Advisor

published Earnings

GMAB is expected to report earnings to fall 2.14% to 31 cents per share on November 06

Genmab A/S ADS GMAB Stock Earnings Reports

Q3'24

Est.

$0.31

Q2'24

Beat

by $0.01

Q1'24

Est.

$0.29

Q4'23

Missed

by $0.17

Q3'23

Est.

$0.47

The last earnings report on August 08 showed earnings per share of 31 cents, beating the estimate of 31 cents. With 484.00K shares outstanding, the current market capitalization sits at 15.44B.

View a ticker or compare two or three

Compare

GMAB

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For GMAB
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for GMAB (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

an international biotechnology company, which develops human antibody therapeutics for the treatment of cancer and other diseases.

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

Carl Jacobsens Vej 30

Phone

+45 70202728

Employees

2204

Web

https://www.genmab.com